10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,727,865 | +53.0% | 405,524 | +107.1% | 0.05% | +52.9% |
| Q2 2023 | $10,934,030 | -4.4% | 195,810 | -4.5% | 0.03% | -17.1% |
| Q1 2023 | $11,434,105 | -42.2% | 204,949 | -62.3% | 0.04% | -42.3% |
| Q4 2022 | $19,787,139 | +4210.9% | 543,006 | +17501.5% | 0.07% | +7000.0% |
| Q4 2021 | $459,000 | -93.9% | 3,085 | -94.1% | 0.00% | -96.3% |
| Q3 2021 | $7,584,000 | +44.1% | 52,094 | +93.8% | 0.03% | +42.1% |
| Q2 2021 | $5,263,000 | -44.8% | 26,879 | -49.0% | 0.02% | -54.8% |
| Q1 2021 | $9,537,000 | +14.9% | 52,693 | -10.1% | 0.04% | +16.7% |
| Q4 2020 | $8,300,000 | +19.2% | 58,617 | +5.0% | 0.04% | +33.3% |
| Q3 2020 | $6,961,000 | +22.7% | 55,833 | -12.1% | 0.03% | -6.9% |
| Q2 2020 | $5,674,000 | – | 63,535 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |